Bilirubin

Bilirubin has been studied in 12 papers since 2015: 8 observational studies in people, 1 in animals, 3 reviews; 2 in the past year. It has not reached trials in people. The newest story, Nov 7, 2026: “Heart transplant survival was similar after two types of donation”.

ExposurePreclinical

12 papers study it265 more mention it9 findingsUpdated

PubChemChEBIMeSH

Research on it is growing 133% faster than aging research as a whole: 13 papers in the latest year counted

18 new papers in 30 daysSee all 277 papers on bilirubin

At a glance

The findings reach people, from one lab or study. 4 independent labs in 4 countries.

“Both unadjusted and adjusted models showed a significant positive association between STB and S-Klotho”
Association Between Bilirubin and Klotho Levels in US Middleaged and Older Adults: NHANES 2007-2016Current molecular medicine2026doi:10.2174/0115665240425215251212075747

1 of its findings points the other way.

Cells, mice and humans: a single group. Worms or flies: nothing yet.
  • 4 independent labs in 4 countries
  • 1 finding against
  • Funders: Czech Academy of Sciences and 5 more
  • 1 of 6 findings with company ties
  • Humans8
  • Animals1

What did studies of bilirubin find?

5

Studies of bilirubin measured 5 outcomes, among them telomere length, oxidative stress and ROS signaling and inflammation.

Telomere length

downin humans1upin humans1upin rats1

2 studies
  1. Bilirubin is linked with lower telomere length in humans (WM p = 0.030 and RAPS p = 0.022 negative; IVW p = 0.124 and MR-Egger p = 0.892 null).

    “the results of the WM (p = 0.030) and RAPS (p = 0.022) were negative, with higher bilirubin concentrations linked to shorter TL”

    Humans

    Serum anti-inflammatory and inflammatory markers have no causal impact on telomere length: a Mendelian randomization study

    Archives of medical science : AMS

  2. Bilirubin is linked with higher telomere length in humans (Gilbert's Syndrome).

    “An occurrence of longer telomeres was observed in male individuals chronically exposed to increased UCB”

    HumansGilbert's SyndromePBMCsmales

    Longer telomeres in chronic, moderate, unconjugated hyperbilirubinaemia: insights from a human study on Gilbert's Syndrome

    Scientific reports

  3. Bilirubin increases telomere length in rats (unconjugated hyperbilirubinaemia).

    “as well as in Gunn rats, an animal model of unconjugated hyperbilirubinaemia.”

    Animalsunconjugated hyperbilirubinaemia

    Longer telomeres in chronic, moderate, unconjugated hyperbilirubinaemia: insights from a human study on Gilbert's Syndrome

    Scientific reports

More on Telomere length

Oxidative stress and ROS signaling

downin human cells1downin rat cells1

1 study
  1. Bilirubin decreases oxidative stress and ROS signaling in rat cells (increasing bilirubin concentrations in culture media).

    “Human embryonic kidney cells and rat primary fibroblasts showed a dose-dependent decrease in the ratio of oxidized/reduced glutathione, intracellular H2O2 levels, and mitochondrial ROS production”

    Cellsincreasing bilirubin concentrations in culture mediaprimary fibroblast

    Hyperbilirubinemia Protects against Aging-Associated Inflammation and Metabolic Deterioration

    Oxidative medicine and cellular longevity

  2. Bilirubin decreases oxidative stress and ROS signaling in human cells (increasing bilirubin concentrations in culture media).

    “Human embryonic kidney cells and rat primary fibroblasts showed a dose-dependent decrease in the ratio of oxidized/reduced glutathione, intracellular H2O2 levels, and mitochondrial ROS production”

    Cellsincreasing bilirubin concentrations in culture mediahuman embryonic kidney cell

    Hyperbilirubinemia Protects against Aging-Associated Inflammation and Metabolic Deterioration

    Oxidative medicine and cellular longevity

More on Oxidative stress and ROS signaling

Inflammation

downin reviews1

1 study
  1. Bilirubin decreases inflammation.

    “By suppressing the NF-κB signaling pathway, it reduces inflammatory factor release and mitigates chronic inflammation.”

    Review

    Bilirubin metabolism and its application in disease prevention: mechanisms and research advances

    Inflammation research : official journal of the European Histamine Research Society ... [et al.]

More on Inflammation

Insulin resistance

upin reviews1

1 study
  1. Bilirubin improves insulin resistance.

    “For metabolic disorders, it improves insulin resistance, regulates blood glucose, and reduces hepatic steatosis, offering therapeutic benefits for diabetes and non-alcoholic fatty liver disease.”

    Review

    Bilirubin metabolism and its application in disease prevention: mechanisms and research advances

    Inflammation research : official journal of the European Histamine Research Society ... [et al.]

Atherosclerosis

downin reviews1

1 study
  1. Bilirubin decreases atherosclerosis.

    “In cardiovascular diseases, it attenuates atherosclerosis and mitigates myocardial ischemia/reperfusion injury.”

    Review

    Bilirubin metabolism and its application in disease prevention: mechanisms and research advances

    Inflammation research : official journal of the European Histamine Research Society ... [et al.]

More on Atherosclerosis

What is bilirubin linked with?

1

Studies link bilirubin with s-Klotho.

s-Klotho

upin humans1

1 study
  1. Bilirubin is associated with s-Klotho in humans (β = 2.84, P = 0.02 in the weighted, fully adjusted model).

    “Both unadjusted and adjusted models showed a significant positive association between STB and S-Klotho”

    Humansn = 4,562

    Association Between Bilirubin and Klotho Levels in US Middleaged and Older Adults: NHANES 2007-2016

    Current molecular medicine

More on s-Klotho

Latest

Dec 2025: 9Jan 2026: 15Feb 2026: 15Mar 2026: 5Apr 2026: 7May 2026: 3Jun 2026: 6Jul 2026: 4Aug 2026: 9Sep 2026: 9Oct 2026: 10Nov 2026: 11103 papers in 12 months
AHA Scientific Sessions 2026 Abstract

Heart transplant survival was similar after two types of donation

Five-year mortality was similar after circulatory-death versus brain-death donation, with a hazard ratio of 0.99 comparing death rates over time.Five-year mortality was similar after circulatory-death versus brain-death donation, with a hazard ratio of 0.99 comparing death rates over time.

Cohort · 21,970 peopleInterventions

See all 277 papers on bilirubin